These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 1249205)

  • 1. Influence of uremia and hemodialysis on the turnover and metabolic effects of glucagon.
    Sherwin RS; Bastl C; Finkelstein FO; Fisher M; Black H; Hendler R; Felig P
    J Clin Invest; 1976 Mar; 57(3):722-31. PubMed ID: 1249205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans.
    Saccà L; Sherwin R; Hendler R; Felig P
    J Clin Invest; 1979 May; 63(5):849-57. PubMed ID: 447832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose intolerance in uremic patients: the relative contributions of impaired beta-cell function and insulin resistance.
    Alvestrand A; Mujagic M; Wajngot A; Efendic S
    Clin Nephrol; 1989 Apr; 31(4):175-83. PubMed ID: 2565775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucose intolerance in uremia. Quantification of pancreatic beta cell sensitivity to glucose and tissue sensitivity to insulin.
    DeFronzo RA; Tobin JD; Rowe JW; Andres R
    J Clin Invest; 1978 Aug; 62(2):425-35. PubMed ID: 353075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-adrenergic contribution to glucagon-induced glucose production and insulin secretion in uremia.
    Baylor P; Shilo S; Zonszein J; Shamoon H
    Am J Physiol; 1986 Sep; 251(3 Pt 1):E322-7. PubMed ID: 3019152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of ketone bodies on glucose production and utilization in the miniature pig.
    Müller MJ; Paschen U; Seitz HJ
    J Clin Invest; 1984 Jul; 74(1):249-61. PubMed ID: 6376544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperglucagonemia in cirrhosis: altered secretion and sensitivity to glucagon.
    Sherwin RS; Fisher M; Bessoff J; Snyder N; Hendler R; Conn HO; Felig P
    Gastroenterology; 1978 Jun; 74(6):1224-8. PubMed ID: 648812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperglucagonemia of renal failure.
    Bilbrey GL; Faloona GR; White MG; Knochel JP
    J Clin Invest; 1974 Mar; 53(3):841-7. PubMed ID: 4812442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of physiologic hyperglucagonemia on basal and insulin-inhibited splanchnic glucose output in normal man.
    Felig P; Wahren J; Hendler R
    J Clin Invest; 1976 Sep; 58(3):761-5. PubMed ID: 956401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of hyperglycemia on glucose uptake and hepatic glucose production in non-dialyzed uremic patients.
    Schmitz O; Arnfred J; Orskov L; Nielsen OH; Orskov H; Posborg V
    Clin Nephrol; 1988 Jul; 30(1):27-34. PubMed ID: 2905213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose, insulin and glucagon response to intravenous glucose load in patients on chronic hemodialysis.
    Shasha SM; Nusem D; Kanter Y; Weiner F
    Isr J Med Sci; 1988 Jan; 24(1):15-9. PubMed ID: 3279011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of glucose on hepatic conversion of aminonitrogen to urea in patients with cirrhosis: relationship to glucagon.
    Hamberg O; Vilstrup H
    Hepatology; 1994 Jan; 19(1):45-54. PubMed ID: 7903954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of tissue sensitivity to insulin in uraemic patients on long-term haemodialysis therapy.
    Schmitz O; Hjøllund E; Alberti KG; Orskov H; Beck-Nielsen H
    Diabetes Res; 1985 Mar; 2(2):57-63. PubMed ID: 4042532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose metabolism in chronic renal failure: adaptive responses to continuous glucose infusion.
    Ricanati ES; Tserng KY; Kalhan SC
    Kidney Int Suppl; 1983 Dec; 16():S121-7. PubMed ID: 6376912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies of carbohydrate metabolism after hemodialysis and hemofiltration in uremic patients.
    Geronemus R; Bosch JP; Thornton J; Rayfield EJ
    Arch Intern Med; 1982 Apr; 142(4):707-10. PubMed ID: 7041844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormone-fuel concentrations in anephric subjects. Effect of hemodialysis (with special reference to amino acids).
    Ganda OP; Aoki TT; Soeldner JS; Morrison RS; Cahill GF
    J Clin Invest; 1976 Jun; 57(6):1403-11. PubMed ID: 932188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneity of plasma glucagon. Circulating components in normal subjects and patients with chronic renal failure.
    Kuku SF; Jaspan JB; Emmanouel DS; Zeidler A; Katz AI; Rubenstein AH
    J Clin Invest; 1976 Sep; 58(3):742-50. PubMed ID: 956399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperglucagonemia and blood glucose regulation in normal, obese and diabetic subjects.
    Sherwin RS; Fisher M; Hendler R; Felig P
    N Engl J Med; 1976 Feb; 294(9):455-61. PubMed ID: 1246330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucagon and insulin binding to liver membranes in a partially nephrectomized uremic rat model.
    Soman V; Felig P
    J Clin Invest; 1977 Jul; 60(1):224-32. PubMed ID: 326810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.